DMAA · Drugs Made In America Acquisition Corp.
$10.71
+0.00 (+0.00%)
At close · Jul 29
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the financial statements are issued. Management plans to address this uncertainty through a Business Combination. There is no assurance that the Company’s plans to raise capital or to consummate a Business Combination will be successful within the Combination Period.”View the 10-Q filed May 14, 2026
Market Cap
$260.01M
Shares
24.28M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-14 | 2,287 | $10.68 | $24,425 |
| 2026-07-13 | 1,887 | $10.68 | $20,153 |
| 2026-07-10 | 2,587 | $10.66 | $27,577 |
| 2026-07-07 | 788 | $10.66 | $8,400 |
| 2026-07-02 | 59 | $10.64 | $628 |
| 2026-07-01 | 165 | $10.65 | $1,757 |
| 2026-06-30 | 1,159 | $10.65 | $12,343 |
| 2026-06-29 | 557 | $10.64 | $5,926 |
| 2026-06-25 | 1,762 | $10.64 | $18,748 |
| 2026-06-24 | 2,043 | $10.64 | $21,738 |
| 2026-06-18 | 1 | $10.62 | $11 |
| 2026-06-17 | 185 | $10.62 | $1,965 |
| 2026-06-16 | 851 | $10.62 | $9,038 |
| 2026-06-10 | 1 | $10.60 | $11 |
| 2026-06-09 | 272 | $10.62 | $2,889 |
| 2026-06-08 | 472 | $10.62 | $5,013 |
| 2026-06-04 | 4,140 | $10.61 | $43,925 |
| 2026-06-03 | 5,964 | $10.61 | $63,278 |
| 2026-06-02 | 8,366 | $10.60 | $88,680 |
Showing 1–19 of 19 settlements
Key facts
CIK
2028614
CUSIP
G2847J104
13F (30d)
1 filings
1 filers